LABCORP HOLDINGS INC. 8-K

What Happened Labcorp Holdings Inc. (the Company) filed an 8-K reporting that on March 20, 2026 it and subsidiary Laboratory Corporation of America Holdings (LCAH) closed a $750,000,000 senior unsecured Term Loan Credit Agreement. Wells Fargo Bank, N.A. acted as administrative agent (with Wells Fargo Securities LLC and PNC firms as arrangers/agents). The Term Loan was fully funded on the closing date and is scheduled to mature on March 20, 2028.

Key Details

• Principal: $750,000,000 senior unsecured term loan, fully funded on March 20, 2026.
• Interest: floating rate — either SOFR-based rate + 0.700% or base rate + 0.0%.
• Maturity: March 20, 2028.
• Financial covenant: consolidated leverage ratio must be ≤ 4.0 to 1.0 quarterly; may elect a temporary “Leverage Holiday” up to 4.5 to 1.0 for four fiscal quarters under specified conditions.
• Other terms: customary representations, affirmative and negative covenants (limits on incurring debt by non‑guarantor subsidiaries, liens, mergers, asset dispositions) and customary events of default (which can trigger acceleration of amounts due).

Why It Matters This filing adds $750M of committed, unsecured borrowing to Labcorp’s capital structure and creates a direct financial obligation that matures in 2028. The leverage covenant and other restrictions may affect the company’s flexibility for future borrowing, acquisitions or disposals if covenant limits are approached. Investors should monitor Labcorp’s reported leverage and any use of the temporary leverage holiday, as well as nearer‑term liquidity and refinancing plans ahead of the 2028 maturity.